Friday, February 10, 2012
Don't let RA limit your routineLearn more now about a treatment that may help

Fablyn Gets A Lukewarm Review from Experts

(Reuters) UPDATED 2010-02-24
The experimental osteoporosis drug Fablyn (lasofoxifene) works as well as current treatments, but not much better, a new study suggests. In a study published in the New England Journal of Medicine, the drug reduced the risk of spinal and non-spinal fractures, but one expert asked to look at the data said the drug left her "underwhelmed." She also suggested there were not enough advantages to Fablyn to warrant changing to a new, unknown medication.
  Read full story >
See all Osteoporosis News

People who read this also read...

  • Why Are My Ocd Symptoms Getting Better?
  • Clonidine Reviews
  • Rsv Not Getting Better With Nebulizer
  • What Are All The Bone Density Tests?
  • Bone Loss In Postmenopausal Women
  • Osteoporosis Statistics